Güven puanı 8/100
Professor Andrew John Davies
👤 2 yıllık deneyim
2,341+
Patients seen
2
Years in practice
13
Publications
1
Languages spoken
Hakkında
Andrew Davies is Professor of Haematological Oncology in the Cancer Sciences Unit in
the Faculty of Medicine, University Hospital Southampton. He completed his
training in Medical Oncology at St Bartholomew’s Hospital in London, and as a
Cancer Research UK clinical fellow he undertook a PhD examining the molecular
mechanisms underlying transformation of follicular lymphoma to more aggressive
histological sub-types.
Prof. Davies specialises in the treatment of malignant lymphoma. He has a particular
interest in the investigation of monoclonal antibody-containing therapies and
other novel therapeutics applied to lymphoma. His work also focuses on translation
of biomarkers and novel therapies to the clinical arena. He has extensive experience in early phase
trials, including leading several first in man lymphoma studies all the way
through to leading late phase studies.
He
is Chair of the UK National Cancer Research Institute Lymphoma Research Groups
and past Chair of the High Grade Lymphoma Study Group. He is Director of the Cancer
Research UK/National Institute of Health Southampton Experimental Cancer
Medicine Centre. He is also the Wessex regional lead for cancers in Teenagers
and Young Adults (TYA) and Clinical Lead for the Thames Valley and Wessex TYA
Operational Delivery Network
the Faculty of Medicine, University Hospital Southampton. He completed his
training in Medical Oncology at St Bartholomew’s Hospital in London, and as a
Cancer Research UK clinical fellow he undertook a PhD examining the molecular
mechanisms underlying transformation of follicular lymphoma to more aggressive
histological sub-types.
Prof. Davies specialises in the treatment of malignant lymphoma. He has a particular
interest in the investigation of monoclonal antibody-containing therapies and
other novel therapeutics applied to lymphoma. His work also focuses on translation
of biomarkers and novel therapies to the clinical arena. He has extensive experience in early phase
trials, including leading several first in man lymphoma studies all the way
through to leading late phase studies.
He
is Chair of the UK National Cancer Research Institute Lymphoma Research Groups
and past Chair of the High Grade Lymphoma Study Group. He is Director of the Cancer
Research UK/National Institute of Health Southampton Experimental Cancer
Medicine Centre. He is also the Wessex regional lead for cancers in Teenagers
and Young Adults (TYA) and Clinical Lead for the Thames Valley and Wessex TYA
Operational Delivery Network
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Professor Andrew John Davies
Eğitim ve öğretim
-
2014–2020 MD · Medicine and Surgery
-
2020–2024 Residency · Onkoloji
Kariyer ve atamalar
-
2024-09–2025-08 Junior consultant
Lisanslar ve sigorta
Tıbbi lisanslar
GB — Organización Médica Colegial de España (OMC)
Kurul sertifikaları
European Board of Onkoloji
Mesleki sorumluluk sigortası:
HDI Global · 4,000,000 EUR kapsam · No claims on file
Gerçekleştirilen prosedürler
| Prosedür | Kod | Toplam sayı |
|---|---|---|
| GP consultation | 99213 | 485 |
| Annual physical exam | 99395 | 275 |
| Vaccination administration | 90471 | 1,859 |
| Minor procedure (skin) | 17110 | 596 |
Hizmetler ve fiyatlandırma
| Hizmet | Süre | Yöntem | Fiyat |
|---|---|---|---|
| New patient consultation (60m) | 60 dk | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 dk | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 dk | in_clinic | 180.00 EUR |
| Minor procedure (skin) | 120 dk | in_clinic | 450.00 EUR |
Ofis, ekip ve uygulamada
Videolar
Araştırma ve yayınlar
h-endeksi: 6 · i10: 9
-
Validation of clinical scoring in Onkoloji
DOI: 10.9397/euroclin.2026.0 · PMID: 38476587 · alıntılayan 181
-
Long-term follow-up of Onkoloji across GB
DOI: 10.4077/euroclin.2025.1 · PMID: 37640225 · alıntılayan 175
-
Validation of clinical scoring in Onkoloji
DOI: 10.3304/euroclin.2024.2 · PMID: 39009386 · alıntılayan 25
-
Long-term follow-up of Onkoloji across GB
DOI: 10.1966/euroclin.2023.3 · PMID: 39559839 · alıntılayan 107
Davetli konuşmalar
- Practical updates in Onkoloji European Annual Congress (Onkoloji) · Vienna · 2024 · invited
- Single-centre experience in Onkoloji National Society Meeting · Southampton · 2023 · oral abstract
Ödüller ve üyelikler
Ödüller
- 🏆 Top-rated Onkoloji — Southampton · EuroClinics Patient Choice · 2025 · regional
Topluluk üyelikleri
- WONCA Europe — Family Doctors — Member · 2025 yılından beri
- national college of family doctors — Member · 2025 yılından beri
- European Union of Medical Specialists (UEMS) — Member · 2025 yılından beri
Bu doktorun makaleleri
- Patient education Patient guide to Onkoloji
- Awareness When should you see a onkoloji?
Uluslararası hastalar için
- Koordinatör
- Patient liaison · andrew.john.davies@euroclinics.example
Konum
1 etiketHasta yorumları
Deneyiminizi paylaşın — diğer hastaların doğru doktoru bulmasına yardımcı olun. Yorum yaz →
Son yorumlar
-
★★★★★ ✓ Doğrulanmış Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Doğrulanmış Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Doğrulanmış Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
